[COLL] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[COLL] Collegium Pharmaceutical, Inc.
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 58.64%
YoY- 4,415.10%
Quarter Report
COLL's Result
COLL's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 159,301 136,709 127,013 78,843 79,176 72,942 70,176 14.62%
PBT 15,580 28,783 1,432 9,037 11,566 -6,109 -16,502 -
Tax 6,245 8,149 975 991 280 -266 5,868 1.04%
NP 9,335 20,634 457 8,046 11,286 -6,109 -16,502 -
Tax Rate -40.08% -28.31% -68.09% -10.97% -2.42% - - -
Total Cost 149,966 116,075 126,556 70,797 67,890 79,051 86,678 9.55%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 5.86 15.09 0.36 10.21 14.25 -8.38 -23.52 -
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS 0.29 0.61 0.01 0.23 0.33 -0.18 -0.50 -
EPS Diluted 0.23 0.53 0.01 0.22 0.32 -0.18 -0.50 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.